![Chris Storgard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Storgard
Hoofd Techniek/Wetenschap/O&O bij
DESIGN THERAPEUTICS, INC.
Vermogen: - $ op 31-08-2026
Profiel
Chris M.
Storgard is currently Chief Medical Officer at Design Therapeutics, Inc. since 2025.
Formerly, Dr. Storgard was Chief Medical Officer at Heron Therapeutics, Inc. from 2019 to 2024, Chief Medical Officer at Fate Therapeutics, Inc. from 2016 to 2018, Vice President-Clinical Research & Development at Ardea Biosciences, Inc. from 2013 to 2016, Member & Assistant Professor at Mayo Medical School from 2001 to 2004, and Chief Medical Officer at ADARx Pharmaceuticals, Inc. Dr. Storgard earned a doctorate from the University of Saskatchewan.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Chris Storgard
| Bedrijven | Functie | Begin |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-04-2025 |
Eerdere bekende functies van Chris Storgard
| Bedrijven | Functie | Einde |
|---|---|---|
| HERON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2024 |
| FATE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 05-11-2018 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Hoofd Techniek/Wetenschap/O&O | 02-01-2016 |
Mayo Medical School
 Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 02-01-2004 |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Chris Storgard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
47
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Mayo Medical School
Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
